iX Biopharma Ltd IXBOF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 1.10B
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
iX Biopharma Ltd is a Singapore-based specialty pharmaceutical and nutraceutical company focused on the development, manufacture, and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. Its products under development are Wafermine and BnoX for pain management, Wafesil for erectile dysfunction, WafeRest for improved sleep quality, and others. Its business segments are the Specialty Pharmaceutical; and Nutraceutical segments. The firm's business segments operate in the United States of America, Australia, China, Singapore and others, of which the majority of the revenue comes from the Australia. The company generates the majority of its revenue from the sale of specialty pharmaceutical products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 48
- Website
- https://www.ixbiopharma.com
Valuation
|
Metric
|
IXBOF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IXBOF
|
|---|---|
Quick Ratio | 1.67 |
Current Ratio | 1.86 |
Interest Coverage | −10.58 |
Quick Ratio
IXBOF
Profitability
|
Metric
|
IXBOF
|
|---|---|
Return on Assets (Normalized) | −39.43% |
Return on Equity (Normalized) | −85.93% |
Return on Invested Capital (Normalized) | −48.08% |
Return on Assets
IXBOF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|Xrb>Y^@ | LOCK|yV#r | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|PMPP<W! | LOCK|>!bk | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|@X#Jvk | LOCK|>%$ | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|m#BZ?!#y | LOCK|Rx | $33B | |||
| Viatris Inc
VTRS
| LOCK|Sr><bv | LOCK|NK | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|ktn | LOCK|c^ | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|ytP$&j | LOCK|>lv | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|Yx$D@>@ | LOCK|q& | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|c%>G!NC | LOCK|?sN?# | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|Ph&XR# | LOCK|Mwg | $2B |
United States